X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs PANACEA BIOTECH - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA PANACEA BIOTECH SANOFI INDIA/
PANACEA BIOTECH
 
P/E (TTM) x 36.5 -6.6 - View Chart
P/BV x 6.9 2.1 322.8% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SANOFI INDIA   PANACEA BIOTECH
EQUITY SHARE DATA
    SANOFI INDIA
Dec-17
PANACEA BIOTECH
Mar-14
SANOFI INDIA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs4,945149 3,325.5%   
Low Rs3,90182 4,740.0%   
Sales per share (Unadj.) Rs1,081.884.1 1,285.7%  
Earnings per share (Unadj.) Rs141.6-18.3 -773.2%  
Cash flow per share (Unadj.) Rs185.9-6.7 -2,775.6%  
Dividends per share (Unadj.) Rs33.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs868.883.7 1,037.9%  
Shares outstanding (eoy) m23.0361.25 37.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.4 297.9%   
Avg P/E ratio x31.2-6.3 -495.3%  
P/CF ratio (eoy) x23.8-17.2 -138.0%  
Price / Book Value ratio x5.11.4 369.0%  
Dividend payout %23.30-   
Avg Mkt Cap Rs m101,8627,074 1,439.9%   
No. of employees `0003.22.8 117.8%   
Total wages/salary Rs m3,6851,449 254.3%   
Avg. sales/employee Rs Th7,691.91,874.1 410.4%   
Avg. wages/employee Rs Th1,137.7527.0 215.9%   
Avg. net profit/employee Rs Th1,006.5-407.7 -246.8%   
INCOME DATA
Net Sales Rs m24,9145,154 483.4%  
Other income Rs m807100 808.6%   
Total revenues Rs m25,7215,254 489.6%   
Gross profit Rs m5,372-766 -701.0%  
Depreciation Rs m1,022711 143.7%   
Interest Rs m111,503 0.7%   
Profit before tax Rs m5,146-2,881 -178.6%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m1,88617 11,226.2%   
Profit after tax Rs m3,260-1,121 -290.7%  
Gross profit margin %21.6-14.9 -145.0%  
Effective tax rate %36.6-0.6 -6,283.9%   
Net profit margin %13.1-21.8 -60.1%  
BALANCE SHEET DATA
Current assets Rs m14,4323,810 378.8%   
Current liabilities Rs m6,0108,365 71.8%   
Net working cap to sales %33.8-88.4 -38.2%  
Current ratio x2.40.5 527.2%  
Inventory Days Days61156 39.1%  
Debtors Days Days2867 42.4%  
Net fixed assets Rs m7,99114,480 55.2%   
Share capital Rs m23061 375.7%   
"Free" reserves Rs m19,778903 2,190.0%   
Net worth Rs m20,0085,127 390.2%   
Long term debt Rs m05,832 0.0%   
Total assets Rs m27,77019,433 142.9%  
Interest coverage x468.8-0.9 -51,153.1%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.90.3 338.3%   
Return on assets %11.82.0 599.7%  
Return on equity %16.3-21.9 -74.5%  
Return on capital %25.83.6 708.8%  
Exports to sales %024.5 0.0%   
Imports to sales %010.2 0.0%   
Exports (fob) Rs mNA1,264 0.0%   
Imports (cif) Rs mNA525 0.0%   
Fx inflow Rs m6,3061,539 409.7%   
Fx outflow Rs m5,257942 558.1%   
Net fx Rs m1,049597 175.7%   
CASH FLOW
From Operations Rs m4,351599 726.1%  
From Investments Rs m-787-438 179.7%  
From Financial Activity Rs m-1,884-303 622.6%  
Net Cashflow Rs m1,680-141 -1,189.0%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 0.6 2,400.0%  
FIIs % 14.6 1.3 1,123.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 23.6 44.5%  
Shareholders   15,184 10,259 148.0%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ALEMBIC PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY18); Net Profit Up 37.5% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SANOFI INDIA has posted a net profit of Rs 825 m (up 37.5% YoY). Sales on the other hand came in at Rs 6 bn (up 11.7% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 22, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS